Sanofi sponsorship draws Aussie fine

Sanofi-Aventis has been slapped with a $25,000 fine for striking a groundbreaking but controversial sponsorship deal that was expected to funnel $500,000 a year into one of Australia's top medical research institutes to help fund its work. A watchdog committee said the deal could interfere with doctor independence. Report

Suggested Articles

Mylan and Pfizer's Upjohn have a name for their pending merger: Viatris. Heard that before? So has Mylan, which owns a subsidiary with the same name.

Intercept presented a data analysis that found treatment with Ocaliva led to "early and consistent improvements" in a range of noninvasive tests.

Days before Amarin faces a pivotal FDA vote on its Vascepa expansion, advisors are set to scrutinize the placebo used in its pivotal outcomes trial.